Table 3.
Laparoscopic group (n = 50) | Open group (n = 59) | P | |
---|---|---|---|
The mean follow-up time (months) | 25.04 ± 18.4 (1–61) | 24.08 ± 13.1 (1–52) | .814 |
Tumor recurrence | 16 (34%) | 23 (39%) | .548 |
Time to recurrence (median) | 9.1 ± 5.9 | 14.8 ± 10.76 | .062 |
Recurrence site | |||
Intrahepatic | 16/16 (100%) | 23/23 (100%) | .449 |
Distant | 5/16 | 5/23 | |
Port-site metastasis | 1 | 0 | |
Ometum implanting | 2 | 0 | |
Lung | 1 | 4 | |
Adrenal | 0 | 2 | |
Brain | 1 | 1 | |
Total mortality | 22% | 25.4% | .764 |
1 year OS | 90.7% | 83.1% | |
3 year OS | 78.1% | 74.4% | .71 |
1 year DFS | 89.6% | 84.7% | |
3 year DFS | 51.4% | 59.6% | .935 |
DFS, disease-free survival; OS, overall survival.